Telehealth can increase health care utilization for substance use disorder (SUD) and mental health (MH) services, particularly for underserved populations. We examined shifts to telehealth for SUD and MH services during the COVID-19 public health emergency and whether they occurred similarly by race, ethnicity, and population density.
Methods:
We used data from the 2021 to 2022 National Survey on Drug Use and Health, focusing on adults with an SUD and/or MH condition in the past year. Estimated prevalence of SUD and MH appointments shifting from in-person to telehealth and used adjusted logistic regression models to examine differences by race, ethnicity, and population density. Sample sizes ranged from 2,440 to 9,695 (∼11–42 million weighted), depending on condition and outcome.
Results:
Approximately 26% of adults with an SUD reported their SUD appointments shifted to telehealth, whereas 66% of adults with an MH condition reported their MH appointments shifted to telehealth. Black (59%) and Latinx (61%) adults with an MH condition were significantly less likely to report appointment shifts to telehealth than White adults (69%, p < 0.01 for both). Individuals in less populated areas were significantly less likely to report their SUD and MH appointments shifted to telehealth, compared with those in highly populated areas.
Conclusion:
Shifts to telehealth were less common for SUD than MH appointments. Rates differed by race and ethnicity. Telehealth was underutilized by those in less populated areas. Research to identify barriers for telehealth services and strategies to ensure telehealth equity in the present day are needed.
AinslieM, BrunetteMF, CapozzoliM. Treatment interruptions and telemedicine utilization in serious mental illness: Retrospective longitudinal claims analysis. JMIR Ment Health2022;9(3):e33092.
3.
YangJ, LandrumMB, ZhouL, et al.Disparities in outpatient visits for mental health and/or substance use disorders during the COVID surge and partial reopening in Massachusetts. Gen Hosp Psychiatry2020;67:100–106.
4.
CouchJV, WhitcombM, BuchheitBM, et al.Patient perceptions of and experiences with stigma using telehealth for opioid use disorder treatment: A qualitative analysis. Harm Reduct J2024;21(1):125.
5.
HandLJ. The role of telemedicine in rural mental health care around the globe. Telemed J E Health2022;28(3):285–294.
6.
JacobsJC, BlonigenDM, KimerlingR, et al.Increasing mental health care access, continuity, and efficiency for veterans through telehealth with video tablets. Psychiatr Serv2019;70(11):976–982.
7.
TilhouAS, DagueL, ChachlaniP, et al.Can telehealth expansion boost health care utilization specifically for patients with substance use disorders relative to patients with other types of chronic disease? PLoS One2024;19(4):e0299397.
8.
FisherK, MaginP. The telehealth divide: Health inequity during the COVID-19 pandemic. Fam Pract2022;39(3):547–549.
9.
HaimiM. The tragic paradoxical effect of telemedicine on healthcare disparities- a time for redemption: A narrative review. BMC Med Inform Decis Mak2023;23(1):95.
10.
KaneCK, GillisK. The use of telemedicine by physicians: Still the exception rather than the rule. Health Aff (Millwood)2018;37(12):1923–1930.
11.
CowanKE, McKeanAJ, GentryMT, et al.Barriers to use of telepsychiatry: Clinicians as gatekeepers. Mayo Clin Proc2019;94(12):2510–2523.
12.
LinL, FernandezAC, BonarEE. Telehealth for substance-using populations in the age of Coronavirus disease 2019: Recommendations to enhance adoption. JAMA Psychiatry2020;77(12):1209–1210.
13.
MolfenterT, BoyleM, HollowayD, et al.Trends in telemedicine use in addiction treatment. Addict Sci Clin Pract2015;10:14.
14.
PerryK, GoldS, ShearerEM. Identifying and addressing mental health providers’ perceived barriers to clinical video telehealth utilization. J Clin Psychol2020;76(6):1125–1134.
15.
CantorJ, McBainRK, KofnerA, et al.Telehealth adoption by mental health and substance use disorder treatment facilities in the COVID-19 pandemic. Psychiatr Serv2022;73(4):411–417.
16.
KrisJ. Telehealth implementation, treatment attendance, and socioeconomic disparities in treatment utilization in a community mental health setting during the COVID-19 pandemic: A retrospective analysis of electronic health record data. Telemed Rep2023;4(1):55–60.
17.
TomlinsonMF, McCann-PineoM, ThomasMP, et al.Demographic differences in services utilization across in-person (2019), telehealth (2020), and hybrid (2021) outpatient substance use services in New York. J Subst Use Addict Treat2023;150:209047.
18.
AndinoJJ, EyrichNW, BoxerRJ. Overview of telehealth in the United States since the COVID-19 public health emergency: A narrative review. Mhealth2023;9:26.
19.
BabarM, ZhuD, LoloiJ, et al.Comparison of patient satisfaction and safety outcomes for postoperative telemedicine vs face-to-face visits in urology: Results of the Randomized Evaluation and Metrics Observing Telemedicine Efficacy (REMOTE) Trial. Urol Pract2022;9(5):371–378; doi: 10.1097/UPJ.0000000000000323
20.
PatelKB, TurnerK, Alishahi TabrizA, et al.Estimated indirect cost savings of using telehealth among nonelderly patients with cancer. JAMA Netw Open2023;6(1):e2250211.
21.
McBainRK, CantorJ, PeraMF, et al.Mental health service utilization rates among commercially insured adults in the US during the first year of the COVID-19 pandemic. JAMA Health Forum2023;4(1):e224936.
22.
McKnight-EilyLR, OkoroCA, StrineTW, et al.Racial and ethnic disparities in the prevalence of stress and worry, mental health conditions, and increased substance use among adults during the COVID-19 pandemic — United States, April and May 2020. MMWR Morb Mortal Wkly Rep2021;70(5):162–166.
23.
RobertsA, RogersJ, MasonR, et al.Alcohol and other substance use during the COVID-19 pandemic: A systematic review. Drug Alcohol Depend2021;229(Pt A):109150.
24.
VakkalankaJP, GadagK, LavinL, et al.Telehealth use and health equity for mental health and substance use disorder during the COVID-19 pandemic: A systematic review. Telemed J E Health2024;30(5):1205–1220.
25.
ChunaraR, ZhaoY, ChenJ, et al.Telemedicine and healthcare disparities: A cohort study in a large healthcare system in New York City during COVID-19. J Am Med Inform Assoc2021;28(1):33–41.
26.
Substance Abuse and Mental Health Services Administration. Disaster technical assistance center supplemental research bulletin: Adaptations and innovations for delivering mental health and substance use disorder treatment services during the COVID-19 pandemic. 2022. Available from: https://www.samhsa.gov/sites/default/files/dtac-adaptations-innovations-covid-19-pandemic.pdf [Last accessed: August11, 2024].
HuskampHA, BuschAB, SouzaJ, et al.How is telemedicine being used in opioid and other substance use disorder treatment? Health Aff (Millwood)2018;37(12):1940–1947.
32.
Uscher-PinesL, CantorJ, HuskampHA, et al.Adoption of telemedicine services by substance abuse treatment facilities in the U.S. J Subst Abuse Treat2020;117:108060.
33.
EdinoffAN, KaufmanSE, ChauncyTM, et al.Addiction and COVID: Issues, challenges, and new telehealth approaches. Psychiatry Int2022;3(2):169–180.
34.
White-WilliamsC, LiuX, ShangD, et al.Use of telehealth among racial and ethnic minority groups in the United States before and during the COVID-19 pandemic. Public Health Rep2023;138(1):149–156.
35.
LinC, PhamH, HserY-I. Mental health service utilization and disparities in the U.S: Observation of the first year into the COVID pandemic. Community Ment Health J2023;59(5):972–985.
36.
ChoiS, HussainS, WangY, et al.Telehealth disparities in outpatient substance use disorder (SUD) treatment among Medicaid beneficiaries during COVID-19. Subst Use Misuse2025;60(7):1007–1015.
37.
SheetsLR, WallachE, KhairatS, et al.Similarities and differences between rural and urban telemedicine utilization. Perspect Health Inf Manag2020;18:1e.
38.
GageAD, KnightMA, BintzC, et al.Disparities in telemedicine use and payment policies in the United States between 2019 and 2023. Commun Med2025;5(1):1–9.
39.
HoganJ, AmspokerAB, WalderA, et al.Differential impact of COVID-19 on the use of tele–mental health among veterans living in urban or rural areas. Psychiatr Serv2022;73(12):1393–1396.
40.
ZhangY, LalL, LinY-Y, et al.Tele-mental health utilization trends with rural–urban disparities in Mississippi: 2020–2023. J Rural Ment Health2024;48(4):219–229.
LiuW, LiJ, DaltonCM. Disruptions to in-person medical visits across the United States during the COVID-19 pandemic: Evolving disparities by medical specialty and socio-economic status. Public Health2023;221:116–123.
AronowitzSV, ZuckerN, ThompsonM, et al.Patient and provider experiences with opioid use disorder care delivered via telehealth: A systematic mixed-studies review. Drug Alcohol Depend2025;266:112522.
45.
BuschAB, SugarmanDE, HorvitzLE, et al.Telemedicine for treating mental health and substance use disorders: Reflections since the pandemic. Neuropsychopharmacology2021;46(6):1068–1070.
46.
BagchiAD, DamasK, Salazar de NogueraN, et al.Comfort with telehealth among residents of an underserved urban area. J Prim Care Community Health2022;13:21501319221119692.
47.
GajarawalaSN, PelkowskiJN. Telehealth benefits and barriers. J Nurse Pract2021;17(2):218–221.
48.
Ruiz-CosignaniD, ChenY, CheungG, et al.Adaptation models, barriers, and facilitators for cultural safety in telepsychiatry: A systematic scoping review. J Telemed Telecare2024;30(3):466–474.
VergésA. On the desirability of social desirability measures in substance use research. J Stud Alcohol Drugs2022;83(4):582–587.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
